Skip to main content
Premium Trial:

Request an Annual Quote

Klaus Sprockamp, Friedrich von Bohlen, Peter Willinger, Douglas Bassett

Premium

At press time, the whereabouts of Lion Bioscience CFO Klaus Sprockamp were still unknown. Sprockamp was attending a meeting in the upper floors of the World Trade Center at the time of the terrorist attacks on New York on September 11.

“Our thoughts are with his family and all the victims,” said Lion CEO Friedrich von Bohlen in a statement. “Lion is working hard to determine what has happened to Mr. Sprockamp.”

In the interim, the finance department is headed by Lion’s corporate controller, Peter Willinger, and Lion said that all other business and company activities are continuing to proceed as usual.

 

Douglas Bassett has been named vice president and general manager of Rosetta Inpharmatics’ new business unit, Rosetta Biosoftware. The new unit will have a staff of 50 and will continue to develop new versions of the Rosetta Resolver gene expression data analysis system.

 

MDS Proteomics has added Hugues Sicotte and Peder Thusgaard Ruhoff to its informatics research team. Sicotte will be responsible for the overall development of the company’s bioinformatics and supercomputing software platform and Ruhoff will lead the company’s efforts to enhance its mass spectrometry software.

Sicotte most recently served as staff scientist at the National Center for Biotechnology Information and Ruhoff was director of the Maersk McKinney Moller Institute for Production Technology at the University of Southern Denmark.

 

Charles Hamner, president and CEO of the North Carolina Biotechnology Center, plans to retire on March 31, 2002.

“After 14 years of productive partnership with so many wonderful people in North Carolina, a refreshment of management is needed as we enter the new era of genomics, bioinformatics and proteomics,” Hamner said in a statement.

The center has begun a national search for Hamner’s replacement.

 

Abgenix has tapped David Miller for the newly created position of vice president, information technology. Miller comes to Abgenix from Somnus Medical Technologies, where he was responsible for the company’s information systems, networks, and telecommunications infrastructure.

 

ArQule has hired Alan Hillyard, formerly senior vice president of cheminformatics research at Lion Bioscience, as CIO. In this position, he will be responsible for ArQule’s information and data management systems, cheminformatics platform, and computational design programs.

Filed under

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.